Related Experiment Video
Updated: Aug 8, 2026
Rat Mesentery Angiogenesis Assay
Published on: June 18, 2011
Selectivity of polyamine involvement in hormone action on normal and neoplastic target tissues of the rat
1Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Abstract:
The present experiments were designed to evaluate the polyamine involvement in hormonal actions on proliferation and receptor content of neoplastic tissue (hormone-responsive breast cancer) as well as on growth of normal endocrine target tissue (uterus) in the same animals. Administration of estradiol and perphenazine (to stimulate endogenous prolactin release) stimulated N-nitrosomethyl-urea (NMU)-induced rat mammary tumor growth following ovariectomy-induced tumor regression. Such hormonal activation of breast cancer growth was completely abolished by treatment with alpha-difluoromethyl-ornithine (DFMO), a specific irreversible inhibitor of ornithine decarboxylase, which lowered tumor content of polyamines. The growth inhibitory effect of DFMO was partially reversible by exogenous putrescine administration. In contrast, the rise in cytosolic content of progesterone receptors induced by hormonal treatment was not affected by suppression of tumor polyamine levels by DFMO. Similarly, DFMO administration failed to influence the hormone-induced increase in uterine weight in the same animals. Thus, our data suggest selectivity of polyamine involvement in hormone actions, which, in our experimental system, seems to be restricted to the endocrine control of neoplastic cell proliferation.
Insights
Polyamines regulate hormone-driven breast cancer growth by influencing cell proliferation. Inhibiting ornithine decarboxylase with alpha-difluoromethyl-ornithine (DFMO) blocked tumor growth, but not receptor changes or uterine growth, indicating selective polyamine involvement.
Area of Science:
- Endocrinology
- Oncology
- Biochemistry
Background:
- Hormonal therapies are crucial for treating hormone-responsive breast cancer.
- Polyamines are essential for cell growth and proliferation.
- The specific role of polyamines in mediating hormonal effects on cancer and normal tissues requires further elucidation.
Purpose of the Study:
- To investigate the role of polyamines in mediating the effects of hormones on breast cancer proliferation and receptor levels.
- To assess the impact of polyamine inhibition on hormone-induced growth of normal uterine tissue.
- To determine the selectivity of polyamine involvement in hormonal actions.
Main Methods:
- N-nitrosomethyl-urea (NMU)-induced rat mammary tumors were used.
- Hormonal stimulation involved estradiol and perphenazine (to increase prolactin).
- Alpha-difluoromethyl-ornithine (DFMO), an ornithine decarboxylase inhibitor, was administered to reduce polyamine levels. Putrescine was used for partial reversal studies.
Main Results:
- Hormonal stimulation of estradiol and prolactin increased NMU-induced mammary tumor growth after ovariectomy.
- DFMO treatment abolished hormone-induced tumor growth by reducing tumor polyamine content.
- DFMO did not affect the increase in progesterone receptors or uterine weight induced by hormonal treatment.
- The growth inhibitory effect of DFMO was partially reversible with putrescine administration.
Conclusions:
- Polyamines are critically involved in mediating the proliferative effects of hormones on breast cancer.
- The role of polyamines appears selective, primarily impacting neoplastic cell proliferation rather than receptor modulation or normal tissue growth.
- Inhibition of polyamine synthesis may offer a targeted therapeutic strategy for hormone-responsive breast cancers.
Related Concept Videos
02:23Abnormal Proliferation
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...